Why Tonix Pharmaceuticals Holding Corp. (TNXP) Soared Last Week

We recently compiled a list of the 10 Micro-, Small-Cap Firms Were Last Week’s Top Performers. In this article, we are going to take a look at where Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) stands against the other stocks.

Micro- and small-cap companies dominated the stock market last week, clocking in impressive gains on the back of a flurry of catalysts that boosted investing appetite.

We named last week’s top 10 performers that outperformed the Russell 2000 index, which dropped by 4.04 percent week-on-week. Among them, one firm particularly stood out with its outstanding 317-percent jump, thanks to a $1-billion deal that could fuel its growth prospects.

To come up with the list, we considered the stocks with the highest week-on-week change, comparing their share prices on March 7 and February 28.

We classified micro-cap companies as those with a market capitalization below $300 million and small-cap firms as those with a market capitalization below $2 billion.

A scientist in a lab coat working with a microscope, researching a biopharmaceutical solution.

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) saw its share price surge by 65.6 percent week-on-week to end Friday at $13.02 versus $7.86 on February 28 as investors bought up shares ahead of an investor summit next week.

Investors repositioned portfolios following news that Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) would present at the 2025 Virtual Investor Summit on Tuesday, March 11, where they would closely look out for cues and updates on its TNX-102 SL, a priority product candidate that aims to manage fibromyalgia.

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) said it expects to receive the decision of the Food and Drug Administration on the marketing authorization of the product on August 15, 2025.

Apart from TNX-102 SL, its portfolio also includes TNX-1300, a biologic in Phase 2 development designed to treat cocaine intoxication.

READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap

Disclosure: None. This article is originally published at Insider Monkey.